EssiLux Sues M&A Target GrandVision Over COVID Information

EssilorLuxottica has filed a legal action to obtain information from its acquisition target GrandVision about its management of the coronavirus crisis, Reuters reported. 

EssilorLuxottica announced a €7.2-billion bid for GrandVision in July last year, aiming to control the Dutch eyewear group’s more than 7,000 outlets across the world. 

It filed the legal proceedings before a district court in Rotterdam, the Netherlands, after GrandVision did not respond to its requests for information on its handling of the pandemic, EssilorLuxottica said in a statement. 

“This is to assess the way GrandVision has managed the course of its business during the COVID-19 crisis, as well as the extent to which GrandVision has breached its obligations under the support agreement,” EssilorLuxottica stated, referring to the terms of the M&A deal. 

“Despite repeated requests, GrandVision has not provided this information on a voluntary basis, leaving EssilorLuxottica with no other option but to resort to legal proceedings,” it added, without elaborating.

GrandVision said in a statement it “strongly disagrees” with EssilorLuxottica’s demands, adding it has “full confidence” that the claims would be rejected in court. 

Earlier this week, EU antitrust authorities extended their investigation on the deal to August 27. 

The coronavirus pandemic has caused setbacks to M&A transactions in recent months, in some cases triggering requests from prospective buyers to amend agreed terms.

Full Content: Reuters

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.